DMD and Duchenne muscular dystrophy: Application of the highly sensitive and quantitative capillary Western immunoassay (Wes) showed that DMD patients produce trace levels of dystrophin in muscle biopsies up to 7% of healthy controls, and that patients with a BMD diagnosis could have dystrophin levels from low (~ 10% of healthy controls) up to 100% of healthy controls16.